Elsevier

Peptides

Volume 26, Issue 11, November 2005, Pages 2331-2338
Peptides

Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity

https://doi.org/10.1016/j.peptides.2005.03.042Get rights and content

Abstract

An orexin-1 receptor antagonist decreases food intake whereas orexin-A selectively induces hyperphagia to a high-fat diet. In the present study, we evaluated the effect of an orexin antagonist in two strains of rats that differ in their sensitivity to becoming obese while eating a high-fat diet. Male Osborne-Mendel (OM) and S5B/Pl (S5B) rats were treated acutely with an orexin-1 receptor antagonist (SB-334867), after adaptation to either a high-fat (56% fat energy) diet or a low-fat (10% fat energy) diet that were equicaloric for protein (24% energy). Ad libitum fed rats were injected intraperitoneally with SB-334867 at doses of 3, 10 or 30 mg/kg, or vehicle at the beginning of the dark cycle, and food intake and body weight were measured. Hypothalamic prepro-orexin and orexin-1 receptor mRNA expression were analyzed in OM and S5B rats fed at a high-fat or low-fat diet for two weeks. SB-334867 significantly decreased food intake in both strains of rats eating the high-fat diet but only in the OM rats eating the low fat diet. The effect was greatest at 12 and 24 h. Body weight was also reduced in OM rats 1 d after injection of SB-334867 but not in the S5B rats. Prepro-orexin and orexin-1 receptor expression levels did not differ between strains or diets. These experiments demonstrate that an orexin antagonist (SB-334867) reduces food intake and has a greater effect in a rat strain that is susceptible to dietary-induced obesity, than in a resistant strain.

Introduction

Obesity is increasingly becoming a threat to modern society [23]. The consequences of obesity are many including diabetes, cardiovascular disease, hypertension and certain types of cancer [36]. Chronic consumption of a high-energy dense diet and a decrease in energy expenditure are associated with modern lifestyles that have contributed to the spread of obesity. Nonetheless, some individuals resist gaining weight without conscious effort in this modern obesigenic environment. Differing susceptibility to obesity in this environment is most likely regulated by genetic or epigenetic factors [30], [31], [44]. As seen in human beings, there are examples of rodents that are susceptible to becoming obese when eating a high-fat diet (Osborne-Mendel rat, C57BL/6J and AKR mice) and of rodents that do not become obese eating a high-fat diet (S5B/Pl rat, SWR and A/J mice).

Osborne-Mendel (OM) and the S5B/Pl (S5B) rats were selected for these experiments because of their various phenotypic differences. When given a two-choice diet with high-fat or high-carbohydrate choices, the OM rats consumed more calories from fat whereas the S5B rats show a preference for carbohydrate [27]. When eating a high-fat diet, OM rats consume more food and become obese in contrast to the S5B rat that gains only a small amount of weight [12]. OM and S5B rats also showed different feeding responses to peptides and drugs. For example, the response to NPY is greater in OM than S5B rats [25]; enterostatin and β-casomorphin, both affected food intake in OM rats eating a high-fat diet but neither had a significant effect on S5B rats [25], [27]. Both β-3AR agonist and leptin suppressed food intake in both strains, but the effects were significantly greater in the S5B rats [18], [46]. The effects of SB-334867 have not previously been tested on high-fat versus low-fat diets; OM and S5B rats will be good models to test its effects.

The neuropeptides orexin-A and orexin-B are processed from a common precursor, prepro-orexin, and its neurons are mainly localized within the lateral hypothalamus (LH) [6], [34]. Orexin-A has high affinity for both orexin receptor-1 (OX1R) and receptor-2 (OX2R) while orexin-B shows a higher affinity to OX2R than to OX1R [34]. OX1Rs are not only expressed in the areas important to energy homeostasis but also co-localised in appetite-regulating neurons such as those producing neuropeptide Y (NPY)/agouti-related peptide (AgRP), proopiomelanocortin (POMC)/cocaine-amphetamine regulated transcript (CART), melanin-concentrating hormone (MCH) and orexin itself in the hypothalamus [1].

Centrally administered orexin-A induces a two-fold increase in food intake [8], [17] and the selective OX1R antagonist, SB-334867, attenuates orexin-A induced feeding and has anorectic effects specific to satiety without inducing behaviors related to nausea [15], [16], [20], [32]. These data indicate that orexin-A-induced hyperphagia is mediated via OX1Rs. One of the most interesting features of SB-334867 is that it induces satiety and has a prolonged anorectic effect [19], [20]. Current evidence on involvement of orexins in dietary-induced obesity is clearly limited. Prepro-orexin knockout mice are prone to dietary-induced obesity [3]. Orexin-A has also been reported to induce selective hyperphagia of the high-fat (HF) diet when rats were given a two-choice diet [5]. While dietary fat has no effect on the expression of orexin-A mRNA or immunoreactivity in the whole hypothalamus [39], [50], high-fat diet has been shown to upregulate orexin mRNA in the perifornical area in mice prone to dietary-induced obesity [2], [47], and lateral hypothalamic orexin-A like immunoreactivity increased after two weeks on a high-fat diet compared with rats fed on a normal fat diet [29]. Therefore, we have used OM and S5B rats to further investigate the effect of an orexin 1R antagonist on ingestion of high- and low-fat diets.

To understand more about the role of OX1Rs in dietary-induced obesity, OM and S5B rats were treated acutely with SB-334867 in Experiment 1. In Experiment 2, prepro-orexin as well as orexin-1 receptor mRNA expression level have been analyzed from the hypothalamus of OM and S5B rats which ate either a high fat or low fat for two weeks. We hypothesized that OX1R would differentially mediate ingestion of HF from LF diets, that the high-fat diet induced hyperphagia in OM rats is due to overactivation of OX1R, and that hypophagia to HF diets in S5B rats is due to defects in the OX1R system.

Section snippets

Animals

Seven-weeks old male Osborne-Mendel and S5B/Pl rats in Experiment 1 and 8–10 week-old male OM and S5B rats in Experiment 2, who were bred in the Pennington Center vivarium, were used in these experiments. Four to five rats were used in each experimental group. All rats were housed singly in hanging wire-bottom stainless steel cages. For Experiment 1, they were adapted to a reversed light-and-dark cycle (22:00 h–10:00 h), and for Experiment 2, a standard 12 h:12 h light–dark cycle (07:00 h–19:00 h)

Experiment 1: effect of SB-334867 in OM and S5B rats

Fig. 1 shows the effect of the orexin antagonist, SB-334867, on food intake in OM and S5B rats. There were significant main effects of treatment [d.f. = 4,60; all F values  3.55, p  0.023] and of diet [d.f.s = 4,60; all F values  31.36, p  0.005] at all time points examined. A significant main effect of strain (OM or S5B rats) was found at 4 and 12 h [d.f. = 1,15; all F values  8.78, p  0.01] and an interaction of treatment and diet at 2 h [F(4,60) = 3.67, p = 0.01]. The other interactions such as treatment and

Discussion

These experiments showed that OM and S5B rats respond differently to an OX1R antagonist, both in body weight and, to a lesser extent, in food intake. The food intake of the OM rats was completely suppressed compared to that of the S5B rats, and the OM rats showed a greater decrease in body weight. These findings suggest that dietary composition did not affect the feeding response to SB-334867 in OM and S5B rats when they are eating a single-choice diet. Thus, SB-334867 (30 mg/kg) suppresses food

Acknowledgments

Research was supported by funding from DK 32089.

References (50)

  • L. Lin et al.

    Enterostatin preferentially reduced fat intake and lowered body weight

    Peptides

    (1997)
  • M. Lubkin et al.

    Independent feeding and metabolic actions of orexins in mice

    Biochem Biophys Res Commun

    (1998)
  • B.J. Oldfield et al.

    The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat

    Neuroscience

    (2002)
  • L.V. Sjostrom

    Mortality of severely obese subjects

    Am J Clin Nutr

    (1992)
  • M.I. Smith et al.

    Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat

    Neurosci Lett

    (2003)
  • M. Szekely et al.

    Effects of orexins on energy balance and thermoregulation

    Regul Pept

    (2002)
  • S. Taheri et al.

    Distribution and quantification of immunoreactive orexin-A in rat tissues

    FEBS Lett

    (1999)
  • S. Taheri et al.

    Diurnal variation in orexin-A immunoreactivity and prepro-orexin mRNA in the rat central nervous system

    Neurosci Lett

    (2000)
  • R.A. Waterland et al.

    Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases

    Nutrition

    (2004)
  • C.L. White et al.

    Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity

    Physiol Behav

    (2004)
  • M. Backberg et al.

    Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake

    Eur J Neurosci

    (2002)
  • G.Q. Chang et al.

    Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus

    Endocrinology

    (2004)
  • R.M. Chemelli et al.

    Metabolic characterization of orexin knockout mice

    Sleep

    (2001)
  • D.J. Clegg et al.

    Eating elicited by orexin-A, but not melanin-concentrating hormone, is opioid mediated

    Endocrinology

    (2002)
  • L. de Lecea et al.

    The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

    Proc Natl Acad Sci USA

    (1998)
  • Cited by (0)

    1

    These authors contributed equally to this work.

    View full text